With healthcare reform dominating headlines and activity in Washington, companies from various parts of the industry are employing different tactics to solidify their position in the debate.
When Pfizer announced in May that it would offer 70 of its prescription drugs for free to US consumers who had lost their jobs, the pharmaceutical company was lauded in the media for its outreach to loyal patients in a challenging economic climate.
Follow-up news stories looked at the program, ...